← back to search

Nicolas Wentzensen

National Cancer Institute · US
Area of research
Epidemiology · Reproductive Medicine
Research interest
Research interests include Cervical Cancer and HPV Research, Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments, and Liver Disease Diagnosis and Treatment.
h-index
119
citations
83,999
works
1,041
NIH funding
$1.3M
primary concept
email

Recent publications

Applying Results of Extended Genotyping to Management of Positive Cervicovaginal Human Papillomavirus Test Results: Enduring Guidelines
Journal of Lower Genital Tract Disease 2025cited by 50position: lastdoi
Self-Collected Vaginal Specimens for HPV Testing: Recommendations From the Enduring Consensus Cervical Cancer Screening and Management Guidelines Committee
Journal of Lower Genital Tract Disease 2025cited by 38position: firstdoi
Screening for Anal Cancer Among Men Who Have Sex With Men With HIV: Benefits, Harms, and Cost-Effectiveness Analyses
Annals of Internal Medicine 2025cited by 10position: middledoi
A Prospective Study Consortium for the Discovery and Validation of Early Detection Markers for Ovarian Cancer – Baseline Findings for CA125
Clinical Cancer Research 2025cited by 4position: middledoi
International Anal Neoplasia Society's consensus guidelines for anal cancer screening
International Journal of Cancer 2024cited by 257position: middledoi
Recommendations for Use of p16/Ki67 Dual Stain for Management of Individuals Testing Positive for Human Papillomavirus
Journal of Lower Genital Tract Disease 2024cited by 53position: middledoi
Understanding risk factors for endometrial cancer in young women
JNCI Journal of the National Cancer Institute 2024cited by 24position: middledoi
Enduring Consensus Guidelines for Cervical Cancer Screening and Management: Introduction to the Scope and Process
Journal of Lower Genital Tract Disease 2024cited by 23position: firstdoi
Criteria for second generation comparator tests in validation of novel HPV DNA tests for use in cervical cancer screening
Journal of Medical Virology 2024cited by 21position: middledoi
Hypertension and Risk of Endometrial Cancer: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2)
Cancer Epidemiology Biomarkers & Prevention 2024cited by 17position: middledoi
Cervical Cancer Screening
JAMA 2023cited by 416position: middledoi
Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population
Nature Medicine 2023cited by 92position: middledoi
Artificial intelligence–based image analysis in clinical testing: lessons from cervical cancer screening
JNCI Journal of the National Cancer Institute 2023cited by 54position: middledoi
Associations of life course obesity with endometrial cancer in the Epidemiology of Endometrial Cancer Consortium (E2C2)
International Journal of Epidemiology 2023cited by 44position: middledoi
2019 ASCCP Risk-Based Management Consensus Guidelines: Updates Through 2023
Journal of Lower Genital Tract Disease 2023cited by 42position: middledoi
A rapid HPV typing assay to support global cervical cancer screening and risk‐based management: A cross‐sectional study
International Journal of Cancer 2023cited by 32position: middledoi
Use of risk-based cervical screening programs in resource-limited settings
Cancer Epidemiology 2023cited by 29position: middledoi
Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis
JNCI Journal of the National Cancer Institute 2023cited by 25position: middledoi
Reproducible and clinically translatable deep neural networks for cervical screening
Scientific Reports 2023cited by 25position: middledoi
Risk prediction models for endometrial cancer: development and validation in an international consortium
JNCI Journal of the National Cancer Institute 2023cited by 22position: middledoi
The combined finding of HPV 16, 18, or 45 and cytologic Atypical Glandular Cells (AGC) indicates a greatly elevated risk of in situ and invasive cervical adenocarcinoma
Gynecologic Oncology 2023cited by 16position: middledoi
Night shift work, sleep duration and endometrial cancer risk: A pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2)
Sleep Medicine Reviews 2023cited by 12position: middledoi
Cervical Cancer Screening: A Review
Obstetrical & Gynecological Survey 2023cited by 11position: middledoi
Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic Susceptibility
JAMA Network Open 2023cited by 11position: middledoi
Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
Cancer Epidemiology Biomarkers & Prevention 2023cited by 6position: middledoi
Racial and Ethnic Disparities in Cervical Cancer Incidence, Survival, and Mortality by Histologic Subtype
Journal of Clinical Oncology 2022cited by 139position: middledoi
A systematic review and meta‐analysis of cytology and HPV‐related biomarkers for anal cancer screening among different risk groups
International Journal of Cancer 2022cited by 116position: lastdoi
Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis
The Lancet Oncology 2022cited by 100position: lastdoi
Colposcopy Standards: Guidelines for Endocervical Curettage at Colposcopy
Journal of Lower Genital Tract Disease 2022cited by 43position: lastdoi
Modification of the Association Between Frequent Aspirin Use and Ovarian Cancer Risk: A Meta-Analysis Using Individual-Level Data From Two Ovarian Cancer Consortia
Journal of Clinical Oncology 2022cited by 30position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mark Schiffman · National Institutes of Health27 papers (2012–2023)Rebecca B. Perkins · Brigham and Women's Hospital25 papers (2017–2025)Philip E. Castle · National Cancer Institute16 papers (2012–2023)Richard S. Guido · University of Pittsburgh15 papers (2017–2025)Francisco García · Hospital Erasto Gaertner13 papers (2012–2025)Warner K. Huh · University of Alabama at Birmingham13 papers (2015–2024)Megan A. Clarke · AbbVie (United States)12 papers (2020–2025) · 12 papers (2020–2025)Li C. Cheung · University of Vermont12 papers (2020–2025)L. Stewart Massad · Georgetown University12 papers (2015–2025)Julia C. Gage · Medical College of Wisconsin10 papers (2012–2023)Thomas Lorey · University of Vermont10 papers (2012–2025)Sílvia de Sanjosé · Global Services (Slovakia)10 papers (2016–2024)Mark H. Einstein · Montefiore Medical Center10 papers (2015–2023)Britton Trabert · University of Utah10 papers (2018–2023)Shelley S. Tworoger · Oregon Health & Science University9 papers (2017–2025)Mona Saraiya · Merck & Co., Inc., Rahway, NJ, USA (United States)8 papers (2012–2023)Debbie Saslow · University of Alabama at Birmingham8 papers (2012–2024)David Chelmow · Virginia Commonwealth University8 papers (2015–2025)Brian Befano · Seattle University8 papers (2020–2023)